Text size Amgen had aid it expected its acquisition of Horizon Therapeutics to be completed in the first half of 2023. Dreamstime Horizon Therapeutics stock plunged 18% early Tuesday on reports that the Federal Trade Commission is set to challenge Amgen ’s $27.8 billion deal to buy the biotech company. The FTC is expected to … Read more
Text size Tesla CEO Elon Musk said he has found a new chief executive for Twitter. Lillian Suwanrumpha/AFP via Getty Images Stock futures were rising Friday as Wall Street came off a mostly down day despite data that showed a further cooling of the U.S. economy. These stocks were poised to make moves Friday: Tesla (TSLA) … Read more
Text size First Republic Bank was downgraded deeper into junk territory by S&P Global. Eric Thayer/Bloomberg Stocks were rising Monday after UBS agreed to acquire Credit Suisse and central banks moved to improve dollar liquidity amid turmoil in the financial sector. These stocks were making moves Monday: American depositary receipts of Swiss bank Credit Suisse … Read more
Text size BridgeBio stock is soaring Monday. Dreamstime BridgeBio Pharma stock was soaring after the biopharmaceutical company reported positive results in a Phase two clinical trial for an experimental treatment for achondroplasia, the most common type of short-limbed dwarfism. On Monday, BridgeBio (ticker: BBIO) said in a news release that its experimental drug Infigratinib showed … Read more
The U.S. stock market, as measured by the S&P 500 Index SPX, -0.73%, had finally broken out over triple resistance at 4100, on Feb. 1. But the S&P 500 has had trouble adding to that breakout. Instead, the market has pulled back and retested what is now support at 4100 numerous times this week. So … Read more
To start 2023, investors will have a choice to invest in a brand new $18 billion company with some 50,000 energized employees and a plan to create shareholder value. To close out 2022, that company—GE HealthCare—is on the road, introducing itself to investors. With each new detail that emerges investors get a better sense of … Read more
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/horizon-therapeutics-coupa-rivian-stock-market-movers-51670601817 Updated Dec. 12, 2022 7:35 am ET / Original Dec. 12, 2022 4:33 am ET Order Reprints Print Article
Amgen Inc. AMGN -2.42% is in advanced talks to buy drug company Horizon Therapeutics HZNP 0.39% PLC, according to people familiar with the matter, in a takeover likely to be valued at well over $20 billion and mark the largest healthcare merger of the year. The U.S. biotechnology company was the last of three suitors … Read more
“Managers,” Peter Drucker wrote, “must understand that business results depend on a balance of efforts and results in a number of areas.” Yet if the Drucker Institute’s measure of corporate effectiveness is any indication, that is much easier said than done.
